Clinical trial
Strontium Ranelate as New Modality in Treatment of Primary Knee Osteoarthritis
NCT03937518 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Strontium Ranelate as New Modality in Treatment of Primary Knee Osteoarthritis
- Lead sponsor
- Mansoura University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 1, 2018
- Completion date
- January 1, 2020
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
knee osteoarthritis